Cargando…
Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared?
At present, extracellular vesicles (EVs) are considered key candidates for cell-free therapies, including treatment of allergic and autoimmune diseases. However, their therapeutic effectiveness, dependent on proper targeting to the desired cells, is significantly limited due to the reduced bioavaila...
Autores principales: | Cieślik, Martyna, Bryniarski, Krzysztof, Nazimek, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354279/ https://www.ncbi.nlm.nih.gov/pubmed/37476156 http://dx.doi.org/10.3389/fcell.2023.1211833 |
Ejemplares similares
-
Increasing the Therapeutic Efficacy of Extracellular Vesicles From the Antigen-Specific Antibody and Light Chain Perspective
por: Nazimek, Katarzyna, et al.
Publicado: (2021) -
Editorial: Extracellular vesicles as potent modulators of immunity
por: Bryniarski, Krzysztof, et al.
Publicado: (2023) -
Extracellular Vesicles—Oral Therapeutics of the Future
por: Cieślik, Martyna, et al.
Publicado: (2022) -
Prenatal Development and Function of Human Mononuclear Phagocytes
por: Miah, Mohi, et al.
Publicado: (2021) -
Advances in the Current Understanding of the Role of Extracellular Vesicles in Allergy, Autoimmunity and Immune Regulation
por: Bryniarski, Krzysztof, et al.
Publicado: (2022)